参芪复方对改善糖尿病血管病变患者IL-6、hs-CRP的临床研究被引量：3

Clinical research on the Shenqi prescription for IL-6、 hs-CRP in patients with diabetic angiopathies

下载PDF

导出

摘要目的:临床观察参芪复方对DA患者hs-CRP、IL-6的影响。方法:将76名2型DA患者随机分成两组,观察其治疗前后IL-6、hs-CRP等指标的变化,并对综合疗效进行评价。结果:治疗组的IL-6、hs-CRP水平较对照组明显下降。结论:参芪复方可有效改善糖尿病血管病变患者的临床症状。 Objective： To observe efficiency of the Shenqi prescription on IL-6 and hs-CRP in patients with diabetic angiopathies. Methods： 76 patients were randomly divided into two groups. Before and after the treatment, IL-6 and hs-CRP in two groups were observed and compared. Results： IL-6 and hs-CRP in the treatment group were decreased more. Conclusion： The Shenqi prescription could improve clinical symptoms of diabetic angiopathies.

作者谢红艳李天浩谢春光

机构地区成都中医药大学附属医院

出处《中医临床研究》 2015年第35期64-65,共2页 Clinical Journal Of Chinese Medicine

基金成都中医药大学附属医院院基金项目项目编号2013-D-YY-24 成都中医药大学校基金资助项目项目编号030018010(ZRMS201308)

关键词参芪复方糖尿病血管病变白介素-6 超敏C-反应蛋白 The Shenqi prescription Diabetic angiopathies IL-6 hs-CRP

分类号 R587.1 [医药卫生—内分泌]

引文网络
相关文献

参考文献2

1朱大龙.炎症与2型糖尿病[J].中国糖尿病杂志,2006,14(1):73-74. 被引量：58
2张红敏,谢春光,陈世伟.低度炎症的中医病因探讨[J].新中医,2005,37(1):14-16. 被引量：39

二级参考文献38

1叶任高.内科学【M】:第5版[M].北京:人民卫生出版社,2000.272,798.
2Koenig W. Inflammation and coronary heart disease: anoverview[J]. Cardiol Rev, 2001,9( 1 ) : 31 - 35.
3Ross R. Atherosclerosis- an inflammatory disease[J]. N Engl J Med, 1999,340:115 - 126.
4Pickup JC, Crook MA. Is type II diabetes mellitus a disease of the innate immune system? [J]. Diabetologia, 1998, 41:1241 - 1248,.
5Henkin L.Zaccaro D,Haffner S,et a1.Cigarette smoking,environmental tobacco smoke exposure and insulin sensitivity:the Insulin Resistance Atherosclerosis Study[J].Am Epidiniol,1999,9(5):290—296.
6Panagiotakos DB,Pitsavos C,Chrysohoou C,et al.Effect of exposure to secondhand smoke on markers of inflammation:the ATHCA study[J].Am J Med,2004,1 16(3):145—150.
7Blake GJ, Ridker PM. Inflammatory mechanisms in atheroscle-rosis: from laboratory evidence to clinical application[J]. ItalHeart J, 2001, 2 ( 11): 796 - 800.
8Guere MM. Adipose tissue hormones[J] .J Endocrinol Invest, 2002, 25(10):855-861.
9Blake GJ, Ridker PM. Inflammatory mechanisms in atherosclerosis: from laboratory evidence to clinical application[J]. Ital Heart J, 2001, 2(11): 796 - 800.
10Koenig W. Inflammation and coronary heart disease: an overview[J]. Cardiol Rev, 2001,9( 1 ) : 31 - 35.